Pharmafile Logo

News and Press Releases

New Data Demonstrate Sunbird Bio’s APEX Diagnostic Test Accurately Differentiates Key Alzheimer’s Disease Biomarker in Blood

Blood-based diagnostic effectively discriminated between patients who were positive versus negative for amyloid beta on PET scans Data will be shared in a poster presentation at AD/PD 2024 on 8-9...

Category: Biotechnology
Posted: March 5, 2024

Sunbird Bio
35 Cambridgepark Drive Suite 100 Cambridge, MA 02140

PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases

New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions 29 February 2024 -- Manchester, UK -- PharmaKure, a clinical stage...

Category: Other
Posted: February 29, 2024

PharmaKure
info@pharmakure.com
Alderley Park Congleton Road Nether Alderley Open Access Lab 19S6 Macclesfield SK10 4TG

Galimedix Therapeutics announces new pre-clinical data with GAL-201 in an Alzheimer’s disease transgenic model to be presented at AD/PD 2024 Conference

Galimedix’s novel, orally administered small molecule offers the hope of changing the course of disease by targeting amyloid beta oligomers and protofibrils 28 February 2024 -- Maryland, US -- Galimedix...

Category: Biotechnology
Posted: February 28, 2024

Galimedix Therapeutics
info@galimedix.com
3704 Calvend Lane Kensington, MD 20895 USA

PharmaKure announces study success for novel blood test to identify biomarkers in patients with Alzheimer’s Disease

Study confirms ALZmetrix whole blood test can detect people at high risk of developing full Alzheimer’s Disease 17 October 2023 -- Manchester, UK -- PharmaKure, a pharmaceutical company spun out...

Category: Clinical Trials, Drug Discovery
Posted: October 17, 2023

PharmaKure
info@pharmakure.com
Alderley Park Congleton Road Nether Alderley Open Access Lab 19S6 Macclesfield SK10 4TG